SOD1 and amyotrophic lateral sclerosis: Furthermore, current therapeutic approaches in fALS aim to mediate metallation status of SOD1 variants, reflecting the significance of metal-binding SOD1 mutants in ALS pathology (Hilton et al., 2015; Tokuda and Furukawa, 2016).